Cognision, provider of advanced neurobiomarker technology, announces its partnership with Kynexis to utilize the COGNISION® System in Kynexis' Phase 2 clinical trial of KYN-5356 in subjects with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback